RE: RE: RE: RE: RE: PAINTING THE TAPEAlways5,
If you are referring to what hurdles does Pharmagap have to clear in order to make it, I would say that the odds are stacked against them. The number of small bios that make to human testing are just a fraction. News releases by Pharmagap and their website presentation paint a very good picture of where they are headed. I believe that the Team put together to take this to human testing is following a specific plan that is all laid out in their website ( click on the .pdf file at the bottom right of their webpage). or here:
https://www.pharmagap.com/pp/pres_aug2010.pdf
If all goes according to plan, we should see marked levels of sustained share value after each stage. I will not put a price on the value of the stock when it reaches human testing, but others have and that is what keeps me interested in this stock. It is a gamble like all others on the Venture., only put in what your are prepared to forfeit. Don't go buying this stock from your line of credit, etc. Remember, all press releases so far have been positive results and we sit at 12 cents. I wonder what would happen if a release stating that the company has to rework the formula again, do we still sit at 12 or do we plummet to a fraction? In the same breathe, if they put out a release like the one we are all waiting for, then this goes to the dollars and we are all rich. It does happen, about as often as hitting the lottery.
It is a gamble. Your job is to pick the right gamble.
Good luck, these are all just MY OPINIONS. I own this stock as a long shot. I have bought on lows and sold on highs and bought back in on lows. It is for fun. Do your own due diligence.